

(Alliance News) - GENinCode PLC on Monday reported improved financial performance in 2023 as the company scaled up operations.


(Alliance News) - GENinCode PLC on Thursday said its risk of ovarian cancer risk test has been recommended as preferred test in England.


GENinCode PLC - biotechnology company focused on prevention of cardiovascular disease - Raises GBP57,378 via a retail offer of 1.1 million shares at a...


GENinCode PLC - biotechnology company focused on prevention of cardiovascular disease - Raises GBP4.0 million via a placing and subscription, announce...